The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Veracyte Inc’s stock clocked out at $40.97, down -2.29% from its previous closing price of $41.93. In other words, the price has decreased by -$2.29 from its previous closing price. On the day, 0.57 million shares were traded. VCYT stock price reached its highest trading level at $42.0 during the session, while it also had its lowest trading level at $40.17.
Ratios:
To gain a deeper understanding of VCYT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.58 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 56.22. For the most recent quarter (mrq), Quick Ratio is recorded 4.79 and its Current Ratio is at 5.08. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on December 05, 2024, Downgraded its rating to Neutral and sets its target price to $37 from $38 previously.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $50.
On October 16, 2024, UBS started tracking the stock assigning a Buy rating and target price of $43.UBS initiated its Buy rating on October 16, 2024, with a $43 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 03 ’25 when Chambers Rebecca sold 527 shares for $43.85 per share. The transaction valued at 23,109 led to the insider holds 113,510 shares of the business.
EASTHAM KARIN sold 10,000 shares of VCYT for $403,006 on Jan 02 ’25. The Director now owns 18,497 shares after completing the transaction at $40.30 per share. On Jan 02 ’25, another insider, KARIN EASTHAM, who serves as the Director of the company, bought 10,000 shares for $39.60 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VCYT now has a Market Capitalization of 3175158784 and an Enterprise Value of 2920874752. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.47 while its Price-to-Book (P/B) ratio in mrq is 2.70. Its current Enterprise Value per Revenue stands at 6.867 whereas that against EBITDA is 66.362.
Stock Price History:
The Beta on a monthly basis for VCYT is 1.77, which has changed by 0.64238155 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, VCYT has reached a high of $47.32, while it has fallen to a 52-week low of $18.61. The 50-Day Moving Average of the stock is -3.80%, while the 200-Day Moving Average is calculated to be 29.12%.
Shares Statistics:
It appears that VCYT traded 785.15K shares on average per day over the past three months and 723930 shares per day over the past ten days. A total of 77.49M shares are outstanding, with a floating share count of 76.51M. Insiders hold about 1.27% of the company’s shares, while institutions hold 99.79% stake in the company. Shares short for VCYT as of 1738281600 were 3151208 with a Short Ratio of 3.88, compared to 1735603200 on 2791964. Therefore, it implies a Short% of Shares Outstanding of 3151208 and a Short% of Float of 4.5300003.